{\rtf \tx504 \li504 \fi-504 \sl240 \slmult1 \sa0 (1)\tab Tautermann, C. S.; Seeliger, D.; Kriegl, J. M. What Can We Learn from Molecular Dynamics Simulations for GPCR Drug Design? {\i{}Computational and Structural Biotechnology Journal} {\b{}2015}, {\i{}13}, 111\uc0\u8211{}121. https://doi.org/10.1016/j.csbj.2014.12.002.
\
(2)\tab Onuchic, J. N.; Wolynes, P. G. Theory of Protein Folding. {\i{}Current Opinion in Structural Biology} {\b{}2004}, {\i{}14} (1), 70\uc0\u8211{}75. https://doi.org/10.1016/j.sbi.2004.01.009.
\
(3)\tab Anderson, A. C. The Process of Structure-Based Drug Design. {\i{}Chemistry & Biology} {\b{}2003}, {\i{}10} (9), 787\uc0\u8211{}797. https://doi.org/10.1016/j.chembiol.2003.09.002.
\
(4)\tab Christen, M.; H\uc0\u252{}nenberger, P. H.; Bakowies, D.; Baron, R.; B\uc0\u252{}rgi, R.; Geerke, D. P.; Heinz, T. N.; Kastenholz, M. A.; Kr\uc0\u228{}utler, V.; Oostenbrink, C.; Peter, C.; Trzesniak, D.; van Gunsteren, W. F. The GROMOS Software for Biomolecular Simulation: GROMOS05. {\i{}J. Comput. Chem.} {\b{}2005}, {\i{}26} (16), 1719\uc0\u8211{}1751. https://doi.org/10.1002/jcc.20303.
\
(5)\tab Macalino, S. J. Y.; Gosu, V.; Hong, S.; Choi, S. Role of Computer-Aided Drug Design in Modern Drug Discovery. {\i{}Arch. Pharm. Res.} {\b{}2015}, {\i{}38} (9), 1686\uc0\u8211{}1701. https://doi.org/10.1007/s12272-015-0640-5.
\
(6)\tab Cournia, Z.; Allen, B.; Sherman, W. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. {\i{}J. Chem. Inf. Model.} {\b{}2017}, {\i{}57} (12), 2911\uc0\u8211{}2937. https://doi.org/10.1021/acs.jcim.7b00564.
\
(7)\tab Krohn, A.; Redshaw, S.; Ritchie, J. C.; Graves, B. J.; Hatada, M. H. Novel Binding Mode of Highly Potent HIV-Proteinase Inhibitors Incorporating the (R)-Hydroxyethylamine Isostere. {\i{}J. Med. Chem.} {\b{}1991}, {\i{}34} (11), 3340\uc0\u8211{}3342. https://doi.org/10.1021/jm00115a028.
\
(8)\tab Ganesan, A.; Coote, M. L.; Barakat, K. Molecular Dynamics-Driven Drug Discovery: Leaping Forward with Confidence. {\i{}Drug Discovery Today} {\b{}2017}, {\i{}22} (2), 249\uc0\u8211{}269. https://doi.org/10.1016/j.drudis.2016.11.001.
\
(9)\tab Durrant, J. D.; McCammon, J. A. Molecular Dynamics Simulations and Drug Discovery. {\i{}BMC Biol} {\b{}2011}, {\i{}9} (1), 71. https://doi.org/10.1186/1741-7007-9-71.
\
(10)\tab Paul, S. M.; Mytelka, D. S.; Dunwiddie, C. T.; Persinger, C. C.; Munos, B. H.; Lindborg, S. R.; Schacht, A. L. How to Improve R&D Productivity: The Pharmaceutical Industry\uc0\u8217{}s Grand Challenge. {\i{}Nat Rev Drug Discov} {\b{}2010}, {\i{}9} (3), 203\uc0\u8211{}214. https://doi.org/10.1038/nrd3078.
\
(11)\tab Jhoti, H.; Rees, S.; Solari, R. High-Throughput Screening and Structure-Based Approaches to Hit Discovery: Is There a Clear Winner? {\i{}Expert Opinion on Drug Discovery} {\b{}2013}, {\i{}8} (12), 1449\uc0\u8211{}1453. https://doi.org/10.1517/17460441.2013.857654.
\
(12)\tab Stone, J. E.; Hardy, D. J.; Ufimtsev, I. S.; Schulten, K. GPU-Accelerated Molecular Modeling Coming of Age. {\i{}Journal of Molecular Graphics and Modelling} {\b{}2010}, {\i{}29} (2), 116\uc0\u8211{}125. https://doi.org/10.1016/j.jmgm.2010.06.010.
\
(13)\tab Chipot, C. Frontiers in Free-Energy Calculations of Biological Systems: WIREs Computational Molecular Science: Frontiers in Free-Energy Calculations. {\i{}WIREs Comput Mol Sci} {\b{}2014}, {\i{}4} (1), 71\uc0\u8211{}89. https://doi.org/10.1002/wcms.1157.
\
(14)\tab Chodera, J. D.; Mobley, D. L. Entropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design. {\i{}Annu. Rev. Biophys.} {\b{}2013}, {\i{}42} (1), 121\uc0\u8211{}142. https://doi.org/10.1146/annurev-biophys-083012-130318.
\
(15)\tab Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and Testing of a General Amber Force Field. {\i{}J. Comput. Chem.} {\b{}2004}, {\i{}25} (9), 1157\uc0\u8211{}1174. https://doi.org/10.1002/jcc.20035.
\
(16)\tab Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. {\i{}J. Comput. Chem.} {\b{}1983}, {\i{}4} (2), 187\uc0\u8211{}217. https://doi.org/10.1002/jcc.540040211.
\
(17)\tab Robinson, B. S.; Riccardi, K. A.; Gong, Y.; Guo, Q.; Stock, D. A.; Blair, W. S.; Terry, B. J.; Deminie, C. A.; Djang, F.; Colonno, R. J.; Lin, P. BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents. {\i{}Antimicrob Agents Chemother} {\b{}2000}, {\i{}44} (8), 2093\uc0\u8211{}2099. https://doi.org/10.1128/AAC.44.8.2093-2099.2000.
\
(18)\tab Rutenber, E. E.; Stroud, R. M. Binding of the Anticancer Drug ZD1694 to E. Coli Thymidylate Synthase: Assessing Specificity and Affinity. {\i{}Structure} {\b{}1996}, {\i{}4} (11), 1317\uc0\u8211{}1324. https://doi.org/10.1016/S0969-2126(96)00139-6.
\
(19)\tab Hou, T.; Wang, J.; Li, Y.; Wang, W. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. {\i{}J. Chem. Inf. Model.} {\b{}2011}, {\i{}51} (1), 69\uc0\u8211{}82. https://doi.org/10.1021/ci100275a.
\
(20)\tab Harvey, M. J.; Giupponi, G.; Fabritiis, G. D. ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. {\i{}J. Chem. Theory Comput.} {\b{}2009}, {\i{}5} (6), 1632\uc0\u8211{}1639. https://doi.org/10.1021/ct9000685.
\
(21)\tab Friedrichs, M. S.; Eastman, P.; Vaidyanathan, V.; Houston, M.; Legrand, S.; Beberg, A. L.; Ensign, D. L.; Bruns, C. M.; Pande, V. S. Accelerating Molecular Dynamic Simulation on Graphics Processing Units. {\i{}J. Comput. Chem.} {\b{}2009}, {\i{}30} (6), 864\uc0\u8211{}872. https://doi.org/10.1002/jcc.21209.
\
(22)\tab Kempf, D. J.; Marsh, K. C.; Denissen, J. F.; McDonald, E.; Vasavanonda, S.; Flentge, C. A.; Green, B. E.; Fino, L.; Park, C. H.; Kong, X. P. ABT-538 Is a Potent Inhibitor of Human Immunodeficiency Virus Protease and Has High Oral Bioavailability in Humans. {\i{}Proc. Natl. Acad. Sci. U.S.A.} {\b{}1995}, {\i{}92} (7), 2484\uc0\u8211{}2488. https://doi.org/10.1073/pnas.92.7.2484.
\
(23)\tab Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. {\i{}J. Am. Chem. Soc.} {\b{}1995}, {\i{}117} (19), 5179\uc0\u8211{}5197. https://doi.org/10.1021/ja00124a002.
\
(24)\tab Bissantz, C.; Kuhn, B.; Stahl, M. A Medicinal Chemist\uc0\u8217{}s Guide to Molecular Interactions. {\i{}J. Med. Chem.} {\b{}2010}, {\i{}53} (14), 5061\uc0\u8211{}5084. https://doi.org/10.1021/jm100112j.
\
(25)\tab Giri, S.; Bader, A. A Low-Cost, High-Quality New Drug Discovery Process Using Patient-Derived Induced Pluripotent Stem Cells. {\i{}Drug Discovery Today} {\b{}2015}, {\i{}20} (1), 37\uc0\u8211{}49. https://doi.org/10.1016/j.drudis.2014.10.011.
\
}